Holen Sie sich die Stockscreener-App
13.00
3.15%
0.29
Schlusskurs vom Vortag:
$12.71
Offen:
$12.68
24-Stunden-Volumen:
58,958
Relative Volume:
0.32
Marktkapitalisierung:
$509.90M
Einnahmen:
$38.63M
Nettoeinkommen (Verlust:
$1.50M
KGV:
137.86
EPS:
0.0943
Netto-Cashflow:
$5.97M
1W Leistung:
+5.30%
1M Leistung:
+11.91%
6M Leistung:
+67.01%
1J Leistung:
+172.56%
1-Tages-Spanne:
$12.68
$13.75
1-Wochen-Bereich:
$11.96
$13.09
52-Wochen-Spanne:
$3.92
$13.31
Brainsway Ltd Adr Stock (BWAY) Company Profile
Firmenname
Brainsway Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare BWAY vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BWAY
Brainsway Ltd Adr
|
13.00 | 496.56M | 38.63M | 1.50M | 5.97M | 0.0943 |
|
ABT
Abbott Laboratories
|
110.19 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
356.34 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
90.08 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.87 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.50 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Brainsway Ltd Adr Stock (BWAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-03-03 | Eingeleitet | Loop Capital | Buy |
| 2021-07-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-20 | Eingeleitet | Northland Capital | Outperform |
| 2019-05-13 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-05-13 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2019-05-13 | Eingeleitet | Oppenheimer | Outperform |
| 2019-05-13 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Brainsway Ltd Adr Aktie (BWAY) Neueste Nachrichten
Northland Securities Comments on Brainsway FY2025 Earnings - MarketBeat
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1 - Sahm
Short Interest in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Declines By 41.9% - MarketBeat
BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026 - ChartMill
BrainsWay to Participate in the Citi 2026 Unplugged MedTech and Life Sciences Access Day - ChartMill
Molson Coors Beverage, Carvana, Avis Budget And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Brainsway Stock Set to Split on Tuesday, March 3rd (NASDAQ:BWAY) - MarketBeat
Brainsway (NASDAQ:BWAY) Reaches New 12-Month HighWhat's Next? - MarketBeat
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Sees Significant Decrease in Short Interest - MarketBeat
Short Interest in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Rises By 116.5% - MarketBeat
Phoenix Financial Ltd. Has $949,000 Stake in Brainsway Ltd. Sponsored ADR $BWAY - MarketBeat
Brainsway (NASDAQ:BWAY) Reaches New 52-Week HighTime to Buy? - MarketBeat
Meta To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Northland Securities Predicts Brainsway Q3 Earnings - MarketBeat
Northland Securities Estimates Brainsway Q1 Earnings - MarketBeat
BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™ - ChartMill
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Short Interest Down 21.1% in December - MarketBeat
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? - sharewise.com
BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD) - Chartmill
BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™ - Chartmill
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Short Interest Update - MarketBeat
Investment Analysts’ Weekly Ratings Updates for Brainsway (BWAY) - Defense World
BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens - Eastern Progress
Are Options Traders Betting on a Big Move in BrainsWay Stock? - sharewise.com
BrainsWay Ltd. (NASDAQ:BWAY) Expanding Reach In Mental Health Care - Kalkine Media
FY2025 EPS Estimate for Brainsway Decreased by Analyst - Defense World
Northland Capmk Reduces Earnings Estimates for Brainsway - MarketBeat
Northland Capmk Predicts Weaker Earnings for Brainsway - Defense World
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21 - GlobeNewswire Inc.
Brainsway (NASDAQ:BWAY) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Brainsway (BWAY) Projected to Post Earnings on Tuesday - Defense World
Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year? - sharewise.com
HC Wainwright Has Bearish Forecast for Brainsway Q4 Earnings - MarketBeat
BrainsWay secures two more U.S. mental health provider investments By Investing.com - Investing.com
Are Medical Stocks Lagging Alkermes (ALKS) This Year? - sharewise.com
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy - The Globe and Mail
Brainsway (NASDAQ:BWAY) Shares Up 1.9%Here's What Happened - MarketBeat
Do Options Traders Know Something About Brainsway Stock We Don't? - sharewise.com
Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Sees Large Increase in Short Interest - MarketBeat
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care - sharewise.com
Insider Trading At ESS Tech Inc (NYSE: GWH): What Did We Note? - stocksregister.com
Finanzdaten der Brainsway Ltd Adr-Aktie (BWAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
1.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):